Japan Oral Solid Dosage Contract Manufacturing Market Size & Outlook
Japan oral solid dosage contract manufacturing market, 2018-2030 (US$M)
Related Markets
Japan oral solid dosage contract manufacturing market highlights
- The Japan oral solid dosage contract manufacturing market generated a revenue of USD 1,636.3 million in 2023 and is expected to reach USD 2,528.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, tablets was the largest revenue generating product in 2023.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
Oral solid dosage contract manufacturing market data book summary
| Market revenue in 2023 | USD 1,636.3 million |
| Market revenue in 2030 | USD 2,528.1 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 4.5% of the global oral solid dosage contract manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India oral solid dosage contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 5,750.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage Contract Manufacturing Market Scope
Oral Solid Dosage Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan oral solid dosage contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 33.42% in 2023. Horizon Databook has segmented the Japan oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
There is a rising demand for biopharmaceutical drugs in Japan to diagnose and treat various chronic diseases. Japan is one of the world's largest pharmaceutical markets, actively involved in improving access to biopharmaceutical drugs.
Furthermore, rapid advancements in drug delivery technology, such as targeted drug delivery and sustained-release dosage forms, are driving the growth of the oral solid dosage contract manufacturing market. Major players in the market include Corden Pharma, Wuxi AppTec, Cambrex Corporation, Recipharm AB, and Lonza.
Reasons to subscribe to Japan oral solid dosage contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan oral solid dosage contract manufacturing market databook
-
Our clientele includes a mix of oral solid dosage contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Japan oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan oral solid dosage contract manufacturing market size, by product, 2018-2030 (US$M)
Japan Oral Solid Dosage Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
